Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years—US, 2015 to 2021-Reference-Cited by-同舟云学术

Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years—US, 2015 to 2021

Published:2024-09-01 Issue:9 Volume:178 Page:940
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Connolly Sarah¹,Terranella Andrew²,Guy Gery P.²,Mikosz Christina A.²

Affiliation:

1. Epidemic Intelligence Service, Division of Overdose Prevention, US Centers for Disease Control and Prevention, Atlanta, Georgia

2. Division of Overdose Prevention, National Center for Injury Prevention and Control, US Centers for Disease Control and Prevention, Atlanta, Georgia

Abstract

This cohort study investigates patterns of buprenorphine treatment retention among US youth aged 10 to 18 years from 2015 to 2021.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamapediatrics/articlepdf/2821647/jamapediatrics_connolly_2024_ld_240025_1724260069.35812.pdf

Reference6 articles.

1. Medication for adolescents and young adults with opioid use disorder.;Society for Adolescent Health and Medicine;J Adolesc Health,2021

2. Buprenorphine dispensing among youth aged =19 years in the US: 2015–2020.;Terranella;Pediatrics,2023

3. Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder.;Hadland;JAMA Pediatr,2018

4. A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.;Marsch;Addiction,2016

5. Association between receipt of antidepressants and retention in buprenorphine treatment for opioid use disorder: a population-based retrospective cohort study.;Zhang;J Clin Psychiatry,2022